The rising prevalence of venous thrombosis and cardiovascular diseases is the primary driver of the global heparin market. Furthermore, the use of heparin in various surgeries, such as orthopaedic and heart surgeries, as well as the increase in the number of patients undergoing such procedures, contribute to the growth of the heparin market. Furthermore, the availability of synthetic and semi-synthetic heparin mimetics that aid in the treatment of cancer, coagulation, and inflammatory diseases is expected to open up new avenues for heparin adoption. Furthermore, increased government support for healthcare infrastructure improvements and comprehensive R&D activities to develop heparin with enhanced therapeutic potential and minimal side effects drive the Heparin Market forward. However, there are numerous negative side effects associated with heparin and the presence of other anticoagulants in the body.
Read More @ https://cmiinfonest.blogspot.com/2023/01/the-global-heparin-market-is-witnessing.html
